Authors:
van de Loosdrecht, AA
Kok, K
de Vries, B
van der Veen, AY
van den Berg, E
Esselink, MT
Marynen, P
Vellenga, E
van Imhoff, GW
Citation: Aa. Van De Loosdrecht et al., Breakpoint analysis by fluorescence in situ hybridization in myelodysplastic syndromes with t(3;12)(q26;p13) and expression of EVI1, LEUKEMIA, 14(10), 2000, pp. 1857-1858
Authors:
Birkenkamp, KU
Esselink, MT
Kruijer, W
Vellenga, E
Citation: Ku. Birkenkamp et al., An inhibitor of PI3-K differentially affects proliferation and IL-6 protein secretion in normal and leukemic myeloid cells depending on the stage of differentiation, EXP HEMATOL, 28(11), 2000, pp. 1239-1249
Authors:
Birkenkamp, KU
Esselink, MT
Kruijer, W
Vellenga, E
Citation: Ku. Birkenkamp et al., Differential effects of interleukin-3 and interleukin-1 on the proliferation and interleukin-6 protein secretion of acute myeloid leukemic cells; theinvolvement of ERK, p38 and STAT5, EUR CYTOKIN, 10(4), 1999, pp. 479-490
Authors:
Birkenkamp, KU
Dokter, WHA
Esselink, MT
Jonk, LJC
Kruijer, W
Vellenga, E
Citation: Ku. Birkenkamp et al., A dual function for p38 MAP kinase in hematopoietic cells: involvement in apoptosis and cell activation, LEUKEMIA, 13(7), 1999, pp. 1037-1045
Authors:
Borger, P
Kauffman, HF
Postma, DS
Esselink, MT
Vellenga, E
Citation: P. Borger et al., Interleukin-15 differentially enhances the expression of interferon-gamma and interleukin-4 in activated human (CD4(+))T lymphocytes, IMMUNOLOGY, 96(2), 1999, pp. 207-214